Cargando…
Phase 1b study on the repurposing of meclizine hydrochloride for children with achondroplasia
Achondroplasia (ACH) is a common skeletal dysplasia characterized by a disproportionately short stature. We found that meclizine, which is an over-the-counter drug for motion sickness, inhibited the fibroblast growth factor receptor 3 (FGFR3) gene using a drug repositioning strategy, and meclizine 1...
Autores principales: | Matsushita, Masaki, Kitoh, Hiroshi, Mishima, Kenichi, Kamiya, Yasunari, Kato, Daisaku, Takemoto, Genta, Sawamura, Kenta, Ueno, Shinji, Yasuhiro, Nakai, Nishida, Kazuki, Imagama, Shiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332602/ https://www.ncbi.nlm.nih.gov/pubmed/37428729 http://dx.doi.org/10.1371/journal.pone.0283425 |
Ejemplares similares
-
Pharmacokinetics and safety after once and twice a day doses of meclizine hydrochloride administered to children with achondroplasia
por: Kitoh, Hiroshi, et al.
Publicado: (2020) -
Effect of periosteal resection on longitudinal bone growth in a mouse model of achondroplasia
por: Kaneko, Shinya, et al.
Publicado: (2020) -
Predictive ability of inflammatory markers and laboratory parameters in Legg-Calvé-Perthes disease: A single-center retrospective comparative study
por: Mishima, Kenichi, et al.
Publicado: (2022) -
Acute osteomyelitis of the patella due to Pseudomonas aeruginosa in an immunocompetent child: A case report
por: Kamiya, Yasunari, et al.
Publicado: (2023) -
Asfotase alfa has a limited effect in improving the bowed limbs in perinatal
benign hypophosphatasia: A case report
por: Matsushita, Masaki, et al.
Publicado: (2021)